Ipamorelina
Selective GH secretagogue (ghrelin receptor / GHS-R agonist)
Selective secretagogue that stimulates pulsatile GH release.
Back to technical sheets- Class
- Selective GH secretagogue (ghrelin receptor / GHS-R agonist)
- Also known as
- Not approved for general clinical use
Mechanism of action
Ghrelin receptor (GHS-R) agonist that stimulates growth-hormone release with relative selectivity, without markedly raising cortisol or prolactin.
Evidence
Preclinical studies and some early safety/pharmacokinetic trials. Not approved for general clinical use. Investigational.
Studied uses
- GH stimulation (research contexts)
Safety considerations
- Stimulating the somatotropic axis is not harmless
- Limited long-term safety data
- Not approved for general human use
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Presentation
- Polvo liofilizado en vial sellado
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.